Mitoxantrone: an active, new antitumor agent with an improved therapeutic index

Cancer Treat Rev. 1987 Dec;14(3-4):297-303. doi: 10.1016/0305-7372(87)90021-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Review

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Clinical Trials as Topic
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use
  • Female
  • Heart Diseases / chemically induced
  • Humans
  • Mitoxantrone / adverse effects
  • Mitoxantrone / therapeutic use*

Substances

  • Doxorubicin
  • Mitoxantrone